OK, I put on my objective thinking hat, but ask that you reveal a little more of your thinking than the typical one liner (jest) of yours (on open board or via pm is fine).
It's in DNDN's interest to raise stock price so as to reduce dilution at each azimuth credit line drawdown. The recent SPA is an industry rarity which reeks of bullish upper management sentiment and places DNDN at a competitive advantage over CEGE in many aspects, but for sure it raised the likelihood of a positive interim, and maintains the nominal power at final, with only a slight detriment in the overall power.
The motivation here clearly is in alignment with retail investors - to avoid dilution by issuing less stocks to Azimuth, so as to not allow thse hedge fund to short more. However, if the company is really not interested preserving small investors interest because they had known provenge is a fake, then my question is why should they care. Just tap into the credit line and fold in 2010. That's why I think you don't make sense.
Now, had this move been taken by any company other than DNDN, given the mother of all proof-of-concept 9901/02a phase 3 studies, the street would have received it well and the stock price gone up, their objective of less diultion been achieved.
AI
